Summary

Global Biomarkers Market 2023-2027
The biomarkers market is forecasted to grow by USD 56,267.85 mn during 2022-2027, accelerating at a CAGR of 13.05% during the forecast period. The report on the biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of heart diseases, growing advancements in genomics and proteomics, and a growing focus on the development of biomarker-based diagnostic methods.
Technavio's biomarkers market is segmented as below:
By Type
• Safety
• Efficacy
• Validation
By Application
• Drug discovery and development
• Diagnostics
• Personalized medicine
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing number of research and development programs and new product launches as one of the prime reasons driving the biomarkers market growth during the next few years. Also, the growing market of biomarkers in emerging economies and the growing use of biomarkers in drug development and clinical trials will lead to sizable demand in the market.
The report on the biomarkers market covers the following areas:
• Biomarkers market sizing
• Biomarkers market forecast
• Biomarkers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biomarkers market vendors that include Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BG Medicine Inc., Bio Techne Corp., CENTOGENE NV, Charles River Laboratories International Inc., DiaSorin Spa, EKF Diagnostics Holdings Plc, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., General Electric Co., Merck KGaA, Meso Scale Diagnostics LLC, Nexus Dx Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc.. Also, the biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/biomarkers-market-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biomarkers market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global biomarkers market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Safety - Market size and forecast 2022-2027
o Exhibit 34: Chart on Safety - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Safety - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Safety - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Safety - Year-over-year growth 2022-2027 (%)
o 6.4 Efficacy - Market size and forecast 2022-2027
o Exhibit 38: Chart on Efficacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Efficacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Efficacy - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Efficacy - Year-over-year growth 2022-2027 (%)
o 6.5 Validation - Market size and forecast 2022-2027
o Exhibit 42: Chart on Validation - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Validation - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Validation - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Validation - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Type
o Exhibit 46: Market opportunity by Type ($ million)
o Exhibit 47: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 48: Chart on Application - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 50: Chart on Comparison by Application
o Exhibit 51: Data Table on Comparison by Application
o 7.3 Drug discovery and development - Market size and forecast 2022-2027
o Exhibit 52: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)
o 7.4 Diagnostics - Market size and forecast 2022-2027
o Exhibit 56: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
o 7.5 Personalized medicine - Market size and forecast 2022-2027
o Exhibit 60: Chart on Personalized medicine - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Personalized medicine - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Personalized medicine - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Personalized medicine - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Application
o Exhibit 64: Market opportunity by Application ($ million)
o Exhibit 65: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories - Overview
o Exhibit 116: Abbott Laboratories - Business segments
o Exhibit 117: Abbott Laboratories - Key news
o Exhibit 118: Abbott Laboratories - Key offerings
o Exhibit 119: Abbott Laboratories - Segment focus
o 12.4 Agilent Technologies Inc.
o Exhibit 120: Agilent Technologies Inc. - Overview
o Exhibit 121: Agilent Technologies Inc. - Business segments
o Exhibit 122: Agilent Technologies Inc. - Key offerings
o Exhibit 123: Agilent Technologies Inc. - Segment focus
o 12.5 Becton Dickinson and Co.
o Exhibit 124: Becton Dickinson and Co. - Overview
o Exhibit 125: Becton Dickinson and Co. - Business segments
o Exhibit 126: Becton Dickinson and Co. - Key news
o Exhibit 127: Becton Dickinson and Co. - Key offerings
o Exhibit 128: Becton Dickinson and Co. - Segment focus
o 12.6 BG Medicine Inc.
o Exhibit 129: BG Medicine Inc. - Overview
o Exhibit 130: BG Medicine Inc. - Product / Service
o Exhibit 131: BG Medicine Inc. - Key offerings
o 12.7 Bio Techne Corp.
o Exhibit 132: Bio Techne Corp. - Overview
o Exhibit 133: Bio Techne Corp. - Business segments
o Exhibit 134: Bio Techne Corp. - Key news
o Exhibit 135: Bio Techne Corp. - Key offerings
o Exhibit 136: Bio Techne Corp. - Segment focus
o 12.8 CENTOGENE NV
o Exhibit 137: CENTOGENE NV - Overview
o Exhibit 138: CENTOGENE NV - Product / Service
o Exhibit 139: CENTOGENE NV - Key offerings
o 12.9 Charles River Laboratories International Inc.
o Exhibit 140: Charles River Laboratories International Inc. - Overview
o Exhibit 141: Charles River Laboratories International Inc. - Business segments
o Exhibit 142: Charles River Laboratories International Inc. - Key news
o Exhibit 143: Charles River Laboratories International Inc. - Key offerings
o Exhibit 144: Charles River Laboratories International Inc. - Segment focus
o 12.10 EKF Diagnostics Holdings Plc
o Exhibit 145: EKF Diagnostics Holdings Plc - Overview
o Exhibit 146: EKF Diagnostics Holdings Plc - Business segments
o Exhibit 147: EKF Diagnostics Holdings Plc - Key offerings
o Exhibit 148: EKF Diagnostics Holdings Plc - Segment focus
o 12.11 Eurofins Scientific SE
o Exhibit 149: Eurofins Scientific SE - Overview
o Exhibit 150: Eurofins Scientific SE - Business segments
o Exhibit 151: Eurofins Scientific SE - Key news
o Exhibit 152: Eurofins Scientific SE - Key offerings
o Exhibit 153: Eurofins Scientific SE - Segment focus
o 12.12 F. Hoffmann La Roche Ltd.
o Exhibit 154: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 155: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 156: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 157: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 158: F. Hoffmann La Roche Ltd. - Segment focus
o 12.13 Meso Scale Diagnostics LLC
o Exhibit 159: Meso Scale Diagnostics LLC - Overview
o Exhibit 160: Meso Scale Diagnostics LLC - Product / Service
o Exhibit 161: Meso Scale Diagnostics LLC - Key offerings
o 12.14 Nexus Dx Inc.
o Exhibit 162: Nexus Dx Inc. - Overview
o Exhibit 163: Nexus Dx Inc. - Product / Service
o Exhibit 164: Nexus Dx Inc. - Key offerings
o 12.15 QIAGEN NV
o Exhibit 165: QIAGEN NV - Overview
o Exhibit 166: QIAGEN NV - Product / Service
o Exhibit 167: QIAGEN NV - Key news
o Exhibit 168: QIAGEN NV - Key offerings
o 12.16 Siemens AG
o Exhibit 169: Siemens AG - Overview
o Exhibit 170: Siemens AG - Business segments
o Exhibit 171: Siemens AG - Key news
o Exhibit 172: Siemens AG - Key offerings
o Exhibit 173: Siemens AG - Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 174: Thermo Fisher Scientific Inc. - Overview
o Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 176: Thermo Fisher Scientific Inc. - Key news
o Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 179: Inclusions checklist
o Exhibit 180: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 181: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 182: Research methodology
o Exhibit 183: Validation techniques employed for market sizing
o Exhibit 184: Information sources
o 13.5 List of abbreviations
o Exhibit 185: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global biomarkers market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Safety - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Safety - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Safety - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Safety - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Efficacy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Efficacy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Efficacy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Efficacy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Validation - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Validation - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Validation - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Validation - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Data Table on Market opportunity by Type ($ million)
Exhibits48: Chart on Application - Market share 2022-2027 (%)
Exhibits49: Data Table on Application - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Personalized medicine - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Personalized medicine - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Personalized medicine - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Personalized medicine - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Application ($ million)
Exhibits65: Data Table on Market opportunity by Application ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: Agilent Technologies Inc. - Overview
Exhibits121: Agilent Technologies Inc. - Business segments
Exhibits122: Agilent Technologies Inc. - Key offerings
Exhibits123: Agilent Technologies Inc. - Segment focus
Exhibits124: Becton Dickinson and Co. - Overview
Exhibits125: Becton Dickinson and Co. - Business segments
Exhibits126: Becton Dickinson and Co. - Key news
Exhibits127: Becton Dickinson and Co. - Key offerings
Exhibits128: Becton Dickinson and Co. - Segment focus
Exhibits129: BG Medicine Inc. - Overview
Exhibits130: BG Medicine Inc. - Product / Service
Exhibits131: BG Medicine Inc. - Key offerings
Exhibits132: Bio Techne Corp. - Overview
Exhibits133: Bio Techne Corp. - Business segments
Exhibits134: Bio Techne Corp. - Key news
Exhibits135: Bio Techne Corp. - Key offerings
Exhibits136: Bio Techne Corp. - Segment focus
Exhibits137: CENTOGENE NV - Overview
Exhibits138: CENTOGENE NV - Product / Service
Exhibits139: CENTOGENE NV - Key offerings
Exhibits140: Charles River Laboratories International Inc. - Overview
Exhibits141: Charles River Laboratories International Inc. - Business segments
Exhibits142: Charles River Laboratories International Inc. - Key news
Exhibits143: Charles River Laboratories International Inc. - Key offerings
Exhibits144: Charles River Laboratories International Inc. - Segment focus
Exhibits145: EKF Diagnostics Holdings Plc - Overview
Exhibits146: EKF Diagnostics Holdings Plc - Business segments
Exhibits147: EKF Diagnostics Holdings Plc - Key offerings
Exhibits148: EKF Diagnostics Holdings Plc - Segment focus
Exhibits149: Eurofins Scientific SE - Overview
Exhibits150: Eurofins Scientific SE - Business segments
Exhibits151: Eurofins Scientific SE - Key news
Exhibits152: Eurofins Scientific SE - Key offerings
Exhibits153: Eurofins Scientific SE - Segment focus
Exhibits154: F. Hoffmann La Roche Ltd. - Overview
Exhibits155: F. Hoffmann La Roche Ltd. - Business segments
Exhibits156: F. Hoffmann La Roche Ltd. - Key news
Exhibits157: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits158: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits159: Meso Scale Diagnostics LLC - Overview
Exhibits160: Meso Scale Diagnostics LLC - Product / Service
Exhibits161: Meso Scale Diagnostics LLC - Key offerings
Exhibits162: Nexus Dx Inc. - Overview
Exhibits163: Nexus Dx Inc. - Product / Service
Exhibits164: Nexus Dx Inc. - Key offerings
Exhibits165: QIAGEN NV - Overview
Exhibits166: QIAGEN NV - Product / Service
Exhibits167: QIAGEN NV - Key news
Exhibits168: QIAGEN NV - Key offerings
Exhibits169: Siemens AG - Overview
Exhibits170: Siemens AG - Business segments
Exhibits171: Siemens AG - Key news
Exhibits172: Siemens AG - Key offerings
Exhibits173: Siemens AG - Segment focus
Exhibits174: Thermo Fisher Scientific Inc. - Overview
Exhibits175: Thermo Fisher Scientific Inc. - Business segments
Exhibits176: Thermo Fisher Scientific Inc. - Key news
Exhibits177: Thermo Fisher Scientific Inc. - Key offerings
Exhibits178: Thermo Fisher Scientific Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations